Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07929298
PHASE2

A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.

View on ClinicalTrials.gov

Summary

The aim of the study is to evaluate the safety and efficacy of oral ecnoglutide tablets in Chinese participants with overweight or obesity

Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Safety and Efficacy of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2026-11-10

Completion Date

2028-01-28

Last Updated

2026-11-10

Healthy Volunteers

No

Interventions

DRUG

ecnoglutide tablet

oral tablet

DRUG

placebo with matching dosage

oral tablet

Locations (1)

The First Affiliated Hospital of Henan University of Science & Technology

Luoyang, Henan, China